DiaGenic ASA (DIAG) - Medical Equipment - Deals and Alliances Profile

Date: July 17, 2014
Pages: 39
Price:
US$ 250.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: DC1D3317112EN
Leaflet:

Download PDF Leaflet

DiaGenic ASA (DIAG) - Medical Equipment - Deals and Alliances Profile
Summary

DiaGenic ASA (DiaGenic) is an innovative diagnostic company. It undertakes the development of novel and patient-friendly in vitro diagnostics (IVD) for early detection of diseases. The company specializes in developing blood-based biomarkers for early detection of Alzheimer’s disease (AD). Its gene signatures have diverse applications in the diagnostic work related to AD. The company’s lead product, ADtect is a blood test that helps distinguish mild to moderate AD from the absence of dementia. The company operates through a single business segment that undertakes the research and development of blood-based gene expression tests within the AD area. The company is also developing three AD diagnostic tests, which are in pipeline. DiaGenic is headquartered in Oslo, Norway.

DiaGenic ASA (DIAG) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope
  • Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
  • Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
  • Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
  • Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
  • Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
  • Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
  • Business Description - A brief description of the company's operations.
  • Key Employees - A list of the key executives of the company.
  • Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
  • Key Competitors - A list of the key competitors of the company.
  • Key Recent Developments - A brief on recent news about the company.
Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements - The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy - The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company - Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers. - The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company - Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research - Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company.
DiaGenic ASA, Medical Equipment, Deals By Year, 2008 to YTD 2014
DiaGenic ASA, Medical Equipment Deals By Type, 2008 to YTD 2014
DiaGenic ASA, Medical Equipment, Deals By Region, 2008 to YTD 2014
DiaGenic ASA, Medical Equipment, Deals By Market, 2008 to YTD 2014
DiaGenic ASA, Medical Equipment, Deals Summary, 2008 to YTD 2014
DiaGenic ASA, Medical Equipment, Deal Details
Partnerships
DiaGenic Enters Into Co-Development Agreement With GE Healthcare
DiaGenic Enters Into Distribution Agreement With Ferrer inCode
DiaGenic Signs Distribution Agreement With GeneKor
DiaGenic Enters Into An Agreement With SRL Ranbaxy
Equity Offering
DiaGenic Announces Rights Offering Of Shares For US$8 Million
DiaGenic Completes Rights Offering Of Shares For US$0.5 Million
DiaGenic Completes Private Placement Of Shares For US$5.2 Million
DiaGenic Completes Public Offering For US$5.14 Million
DiaGenic Completes Private Placement For US$12 Million
DiaGenic Completes Private Placement Of US$1.62 Million
DiaGenic Completes Private Placement Of US$6.14 Million
DiaGenic Completes Private Placement Of US$1.44 Million
DiaGenic Completes Public Offering Of US$8.83 Million
DiaGenic ASA - Key Competitors
Key Employees
Locations And Subsidiaries
Head Office
Recent Developments
Financial Announcements
Feb 20, 2014: DiaGenic: Report from Fourth Quarter 2013
Nov 11, 2013: DiaGenic To Present results for third quarter 2013
Oct 28, 2013: DiaGenic ASA: New Date for Presentation of Report for Third Quarter 2013
Aug 23, 2013: DiaGenic ASA: Report from second quarter 2013
May 14, 2013: DiaGenic Reports Q1 2013 Results
Mar 20, 2013: DiaGenic Reports 2012 Results
Corporate Communications
Mar 20, 2014: DiaGenic Appoints New CEO
Jan 31, 2014: DiaGenic: New CEO and New Company Address
Nov 22, 2013: Extraordinary general meeting held in DiaGenic ASA
Nov 22, 2013: Extraordinary General Meeting held in DiaGenic
Oct 23, 2013: DiaGenic ASA: Request for Extraordinary General Meeting
May 27, 2013: Leading Alzheimer’s disease expert Charles DeCarli, M.D., joins DiaGenic’s Scientific Advisory Board
May 23, 2013: DiaGenic Appoints Hanne Skaarberg Holen As Chairman
Product News
Jan 23, 2014: DiaGenic reports AMYtect study results
Oct 29, 2013: DiaGenic provides update on AMYtect study
Oct 10, 2013: DiaGenic Provides Study Results and Update on Key Clinical Programs
Jul 29, 2013: DiaGenic provides update on key clinical programs
Clinical Trials
Jan 23, 2014: DiaGenic reports AMYtect study results
Oct 29, 2013: DiaGenic provides update on AMYtect study
Oct 10, 2013: DiaGenic Provides Study Results and Update on Key Clinical Programs
Jul 29, 2013: DiaGenic provides update on key clinical programs
Other Significant Developments
Nov 13, 2013: DiaGenic ASA: Report from third quarter 2013
Oct 28, 2013: DiaGenic Prepares Restructuring, Trade Sale or Assets Sale
Aug 26, 2013: DiaGenic Implements Cost Reduction Program
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

DiaGenic ASA, Medical Equipment, Key Facts, 2013
DiaGenic ASA, Medical Equipment, Deals By Year, 2008 to YTD 2014
DiaGenic ASA, Medical Equipment, Deals By Region, 2008 to YTD 2014
DiaGenic ASA, Medical Equipment, Deals By Market, 2008 to YTD 2014
DiaGenic ASA, Medical Equipment, Deals Summary, 2008 to YTD 2014
DiaGenic ASA, Medical Equipment, Deals By Year, 2008 to YTD 2014
DiaGenic ASA, Medical Equipment Deals By Type, 2008 to YTD 2014
DiaGenic ASA, Medical Equipment, Deals By Region, 2008 to YTD 2014
DiaGenic ASA, Deals By Market, 2008 to YTD 2014
DiaGenic ASA, Medical Equipment, Deals Summary, 2008 to YTD 2014
DiaGenic Enters Into Co-Development Agreement With GE Healthcare
DiaGenic Enters Into Distribution Agreement With Ferrer inCode
DiaGenic Signs Distribution Agreement With GeneKor
DiaGenic Enters Into An Agreement With SRL Ranbaxy
DiaGenic Announces Rights Offering Of Shares For US$8 Million
DiaGenic Completes Rights Offering Of Shares For US$0.5 Million
DiaGenic Completes Private Placement Of Shares For US$5.2 Million
DiaGenic Completes Public Offering For US$5.14 Million
DiaGenic Completes Private Placement For US$12 Million
DiaGenic Completes Private Placement Of US$1.62 Million
DiaGenic Completes Private Placement Of US$6.14 Million
DiaGenic Completes Private Placement Of US$1.44 Million
DiaGenic Completes Public Offering Of US$8.83 Million
DiaGenic ASA, Key Competitors
DiaGenic ASA, Key Employees

LIST OF FIGURES

DiaGenic ASA, Medical Equipment, Deals by Type, 2008 to YTD 2014
DiaGenic ASA, Medical Equipment, Deals By Year, 2008 to YTD 2014
DiaGenic ASA, Medical Equipment, Deals by Type, 2008 to YTD 2014
DiaGenic ASA, Medical Equipment, Deals By Region, 2008 to YTD 2014
DiaGenic ASA, Medical Equipment, Deals by Market, 2008 to YTD 2014
Skip to top


Ask Your Question

DiaGenic ASA (DIAG) - Medical Equipment - Deals and Alliances Profile
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: